Delayed sodium channel inactivation mimics long QT: Syndrome 3

Journal of Cardiovascular Pharmacology

Volumn 42, Issue 1, 2003, Pages 113-117

  Kühlkamp, Volker ^a,b   Mewis, Christian ^a   Bosch, Ralph ^a   Seipel, Ludger ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Acquired QT syndrome; Sodium channel; Torsades de pointes

Indexed keywords

4 [3 (4 BENZHYDRYL 1 PIPERAZINYL) 2 HYDROXYPROPOXY] 1H INDOLE 2 CARBONITRILE; SODIUM CHANNEL;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; ELECTROCARDIOGRAM; ELECTROPHYSIOLOGY; FEMALE; HEART VENTRICLE TACHYCARDIA; HUMAN; INFUSION; LONG QT SYNDROME; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SINGLE BLIND PROCEDURE; SODIUM CHANNEL INACTIVATION; SYNDROME DELINEATION; TORSADE DES POINTES;

CARDIOTONIC AGENTS; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGY; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; LONG QT SYNDROME; MALE; PIPERAZINES; SINGLE-BLIND METHOD; SODIUM CHANNELS; TACHYCARDIA, VENTRICULAR;

EID: 0038054087     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200307000-00017     Document Type: Article

References (20)

1. + channels by DPI 201-106. J Membrane Biol. 1986;89:163-172.
2. Scholtysik G, Salzmann R, Berthold R, et al. DPI 201-106, a novel cardioactive agent. Combination of cAMP-independent positive inotropic, negative chronotropic, action potential prolonging and coronary dilatory properties. Naunyn Schmiedebergs Arch Pharmacol. 1985;329:316-325.
3. Nattel S. Acquired delayed rectifier channelopathies: how heart disease and antiarrhythmic drugs mimic potentially-lethal congenital cardiac disorders. Cardiovasc Res. 2000;48:188-190.
4. Camm AJ, Janse MJ, Roden DM, et al. Congenital and acquired long QT syndrome. Eur Heart J. 2000;21:1232-1237.
5. Bazett HC. An analysis of the time-relations of electrocardiograms. Heart. 1920;7:353-370.
6. Roden DM, Lazzara R, Rosen M, et al. Multiple mechanisms in the long-QT syndrome: current knowledge, gaps, and future directions. Circulation. 1996;94:1996-2012.
7. Wang Q, Shen J, Splawski I, et al. SCN5A Mutations Associated with an Inherited Cardiac Arrhythmia, Long QT Syndrome. Cell. 1995;80:805-811.
8. Bennett PB, Yazawa K, Makita N, et al. Molecular mechanism for an inherited cardiac arrhythmia. Nature. 1995;376:683-685.
9. Priori SG, Napolitano C, Cantú F, et al, Differential response to Na+ channel blockade, beta-adrenergic stimulation, and rapid pacing in a cellular model mimicking the SCN5A and HERG defects present in the long-QT syndrome. Circ Res. 1996;78:1009-1015.
10. El-Sherif N, Caref EB, Yin H, et al. The electrophysiological mechanism of ventricular arrhythmias in the long QT syndrome. Circ Res. 1996;79:474-492.
11. Shimizu W, Antzelevitch C. Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsades de pointes in LQT2 and LQT3 models of the long QT syndrome. Circulation. 1997;96:2038-2047.
12. Moss AJ, Zareba W, Benhorin J, et al. ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome. Circulation. 1995;92:2929-2934.
13. Krishnan SC, Galvin J, McGovern B, et al. Reproducible induction of 'atypical' torsades de pointes by programmed electrical stimulation: a novel form of sotalol-induced proarrhythmia? J Cardiovasc Electrophysiol. 1997;8:1055-1061.
14. Novosel D, Hof A, Zierhut W, et al. Proarrhythmic effects of DPI 201-106 elicited with programmed electrical stimulation: a comparison with sotalol. J Cardiovasc Pharmacol. 1993;21:967-972.
15. Pham TV, Rosen MR. Sex, hormones, and repolarization. Cardiovasc Res. 2002;53:740-751.
16. Butrous GS, Debbas NM, Erwin J, et al. Clinical cardiac electrophysiologic evaluation of the positive inotropic agent, DPI 201-106. Eur Heart J. 1988;9:489-497.
17. Makita N, Horie M, Nakamura T, et al. Drug-induced long-QT syndrome associated with a subclinical SCN5A mutation. Circulation. 2002;106:1269-1274.
18. Napolitano C, Schwartz PJ, Brown AM, et al. Evidence for a cardiac ion channel mutation underlying drug-induced QT prolongation and life-threatening arrhythmias. J Cardiovasc Electrophysiol. 2000;11:691-696.
19. Thandroyen FT, Morris AC, Hagler HK, et al. Intracellular calcium transients and arrhythmia in isolated heart cells. Circ Res. 1991;69:810-819.
20. Ferrier GR, Moffat MP, Lukas A. Possible mechanisms of ventricular arrhythmias elicited by ischemia followed by reperfusion. Studies on isolated canine ventricular tissues. Circ Res. 1985;56:184-194.